16 publications

Name Date Type Actions

Double-digit growth in 2021

Total Group Sales: €521 million (up 21.9% as reported)
Annual Sale of Essential products: €296 million (up 34.0% as reported)

 		20/01/2022 Public releases

2021 Annual results

ALL FINANCIAL INDICATORS UP.
Annual sales: €521m (up 21.9% as reported).
Essentials sales: €296m (up 34.0% as reported).
EBIT before depreciation of acquired assets: €101m (up 54.5%).
Net income - Group share: €63m (up 226.9%).

 		24/03/2022 Public releases

Q1 2022 SALES: €135M

Q1 2022 SALES: €135M
(UP 5.5% AS REPORTED, UP 2.2% AT CONSTANT EXCHANGE RATES)
Q1 2022 ESSENTIALS SALES: €77M
(UP 8.1% AS REPORTED, UP 5.5 AT CONSTANT EXCHANGE RATES)

 		13/04/2022 Public releases

General annual meeting - may 19 2022

Annual General Meeting on May 19, 2022 - convocation

 		19/04/2022 Shareholders´s Meeting

Vote by post / proxy form

Vote by post of proxy form for annual general meeting on May 19, 2022

 		19/04/2022 Shareholders´s Meeting

Availability of the 2021 universal registration document

Vetoquinol informs that it has filed its 2021 Universal Registration Document with the Autorité des Marchés Financiers (AMF) on April 22th, 2022.

 		22/04/2022 Public releases

Annual general meeting 2022 - brochure

 		28/04/2022 Shareholders´s Meeting

Number of voting rights and shares making of the share capital

Information regarding the total number of voting rights and shares making of the share capital  - J-21 before AGM as per articles L233-8-II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

 		03/05/2022 Shareholders´s Meeting

Balo new information

Balo new information

 		05/05/2022 Shareholders´s Meeting

Information regarding the total number of voting rights and shares making of the share capital - 12 may 2022

As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers»

 		13/05/2022 Shareholders´s Meeting